French hospital launches major 5-Year hunt for clues on cancer immunotherapy
NCT ID NCT05223608
Summary
This study aims to create a detailed database and biobank of 500 adults with solid tumors who are starting immunotherapy. The goal is to observe how well the treatments work and what side effects occur in real-world patients over five years. Researchers will collect health data and blood samples to identify factors linked to better survival, treatment response, and safety risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Oscar Lambret
RECRUITINGLille, Hauts-de-France, 59, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.